---
document_datetime: 2023-09-21 19:03:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ruconest-epar-all-authorised-presentations_en.pdf
document_name: ruconest-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.1209476
conversion_datetime: 2025-12-22 20:52:39.19839
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Immediate Packaging                        | Content (concentration)       | Pack size                                                                                                    |
|------------------|-------------------|------------|-----------------------------------------------|---------------------------|--------------------------------------------|-------------------------------|--------------------------------------------------------------------------------------------------------------|
| EU/1/10/641/001  | Ruconest          | 2100 U     | Powder for solution for injection             | Intravenous use           | vial (glass)                               | 2100 U                        | 1 vial                                                                                                       |
| EU/1/10/641/002  | Ruconest          | 2100 U     | Powder and solvent for solution for injection | Intravenous use           | Powder: vial (glass) Solvent: vial (glass) | Powder: 2100 U Solvent: 20 ml | 1 vial + 1 vial + 2 vial adapters + 1 syringe + 1 infusion set + 2 alcohol swabs +1 sterile swab + 1 plaster |